Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: Valley Institute of Research
Location: 1821 Sesame Dr. Suite 2, Harlingen, TX 78550, United States
Lead Researcher: Samuel Landero, MD
IRB Committee: This study has been reviewed and approved by the Advarra Institutional Review Board

Background

According to the World Health Organization (WHO), as of September 2020, the ongoing COVID-19 pandemic has resulted in 33,206,004 confirmed cases of COVID-19, including 999,239 deaths. COVID-19 can cause acute respiratory distress syndrome and fatal pneumonia. Effective interventions to prevent or treat COVID-19 remain limited. Management is limited to supportive care and treatment is limited to being vaccinated.

Researchers are investigating whether or not a new potential therapy will prevent an individual from ever contractracting the COVID-19 virus. This potential therapy is a non-vaccine product and will be administered through an injection. 

Interested participants must be at least 18 years old who have been exposed to someone positive with COVID-19. Participants must be willing to comply with all the study requirements.

Why Participate? 

• You may have the opportunity to reduce the risk of getting the COVID-19 infection. 
• You may help develop a potential preventative care for COVID-19 that is a non-vaccine product.
• You may contribute valuable information that may benefit many others in the future.
• You will be compensated up to $707 for participating in this study and completing all study endpoints.
• You will be helping to advance medical and COVID-19 research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Participants who are at least 18 years of age. 
• Participants must have been exposed to someone positive with COVID-19 within the past 8 days. This person can be either symptomatic or asymptomatic. Individuals who work in the following sectors may be viable candidates:
  • Industrial (including but not limited to meatpacking plants)
  • Military (including but not limited to barracks, ships, or other close-quarter working environments) 
  • Healthcare facilities
  • University or College dormitories
  • Long term care facilities (i.e., skilled nursing homes, assisted living homes, independent living residences for the elderly)
• Participants must be able to attend a minimum of 7 study visits at the research site over approximately 12 months. Other additional visits may be required throughout the study. Such additional visits will result in additional reimbursement. 
• Participants may be asked to wear a digital health device as instructed by the study team.

About the Research Centers:

Please note:

Due to the current situation with the COVID-19 pandemic, the researchers would like to assure the participants that ensuring the safety of the participants as well as the study staff is of utmost importance.